Proteolysis of protein C in pooled normal plasma and purified protein C by activated protein C (APC)

被引:5
作者
Hassouna, H [1 ]
Quinn, C [1 ]
机构
[1] Michigan State Univ, Ctr Clin, Dept Med, E Lansing, MI 48824 USA
关键词
resistance to APC; APC-catalyzed protein C activation; protein C deficiency; thrombosis; factor V mutation;
D O I
10.1016/S0301-4622(01)00267-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein C is a vitamin-K dependent zymogen of the anti-coagulant serine protease activated protein C (APO. In this paper. we report four lines of evidence that APC can activate protein C in pooled normal plasma, and purified protein C. First, the addition of APC to protein C-deficient plasma supplemented with protein C produces a prolongation of the clotting time of plasma that is proportional to the amount of protein C. This behavior was observed with APC from the Chromogenix APC resistance kit (Dia Pharm, Franklin, OH, USA) and from APC derived from the thrombin activation of human protein C (Enzyme Research Laboratories, South Bend, IN, USA). Secondly, using immunoblotting after gel electrophoresis, the disappearance of epitopes for monoclonal antibodies that recognize protein C but not APC indicates a time course for the activation by APC of protein C in pooled normal plasma and protein C purified from plasma. Thirdly, the same time course for the disappearance of protein C specific epitope can be followed using ELISA. Finally, protein C can be activated by APC as indicated by the increase in APC specific synthetic substrate Tryp-Arg-Arg-p nitroaniline hydrolysis. Kinetic data indicate a value of 4.7+/-0.4 mM(-1) s(-1) for the activation of protein C by APC under physiological conditions and in the presence of calcium. These observations document that APC must function not only in the inactivation of activated factors V and VIII, but also in the activation of protein C, This additional action of APC may be important to consider more broadly because of APC in the treatment of sepsis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:109 / 124
页数:16
相关论文
共 61 条
[1]  
Alhenc-Gelas M, 2000, THROMB HAEMOSTASIS, V83, P86
[2]   A simple method for the determination of individual rate constants for substrate hydrolysis by serine proteases [J].
Ayala, YM ;
Di Cera, E .
PROTEIN SCIENCE, 2000, 9 (08) :1589-1593
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]  
BERTINA RM, 1982, THROMB HAEMOSTASIS, V48, P1
[6]  
Bovill EG, 1999, THROMB HAEMOSTASIS, V82, P662
[7]   HIGH-STABILITY OF DILUTE HUMAN ALPHA-THROMBIN IN SALT-SOLUTIONS [J].
BREZNIAK, DV ;
HASSOUNA, HI ;
FENTON, JW .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) :847-848
[8]   CONGENITAL PROTEIN-C DEFICIENCY AND VENOUS THROMBOEMBOLISM - A STUDY OF 3 DUTCH FAMILIES [J].
BROEKMANS, AW ;
VELTKAMP, JJ ;
BERTINA, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (06) :340-344
[9]   ARGATROBAN, A SELECTIVE, POTENT THROMBIN INHIBITOR [J].
BUSH, LR .
CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (03) :247-263
[10]  
CALLAS D, 1995, THROMB HAEMOSTASIS, V74, P473